Tech Blast | Comprehensive genomic profiling in cancer

Cancer research Diagnostics and preclinical PCR and sequencing

In this Tech Blast episode, our Digital Editor Annie Coulson talks with Carlo Messina, Senior Director for Oncology in Global Development and Medical Affairs at Roche (Basel, Switzerland), about the use of comprehensive genomic profiling (CGP) in cancer research.

CGP can obtain more information about a tumor from a smaller biospecimen compared with other genomic profiling techniques and gives oncologists more tools for treating patients. Carlo talks about the applications of CGP, including detecting genomic aberrations in the bloodstream, and the future of this technique.

Contents:

  • Introduction: 00:00-00:50
  • What is CGP and what is it used for? 00:50-02:19
  • What other methods are available for investigating the genomic profiles of tumors? 02:19-04:39
  • How do the methods that you mentioned compare to CGP? 04:39-06:54
  • How do you think CGP could improve the cancer treatment landscape? 06:54-10:37
  • Are there any exciting applications of CGP? 10:37-12:37
  • What are your hopes for the technique? 12:37-14:45
  • Closing remarks: 14:45-16:10

This feature was supported by Roche.

 

Submit Your Research to the F1000Research Oncology Gateway

Share your oncology research with the global scientific community through the F1000Research Oncology Gateway. With trusted publishing, open access, and transparent peer review, your work will uphold the highest standards of research integrity while driving innovation in cancer treatment and understanding.

Join a trusted platform that accelerates progress in oncology. Submit your research today at F1000Research Oncology Gateway.